Matthew Zibelman Free People Check 

( I'm Matthew Zibelman)

Loading...

Images of Matthew Zibelman

(0 from 0 )

News

Combination of Axitinib and Nivolumab Safe for …

www.foxchase.org
Matthew Zibelman, MD, assistant professor in the Department of Hematology/Oncology at Fox Chase Cancer Center, leads the multi-center trial of the combination of Axitinib and the PD-1 inhibitor Nivolumab. He will present the safety and early efficacy data for the phase I cohort as part of the ASCO annual meeting. Axitinib is an oral targeted agent and Nivolumab is an immunotherapy drug ...

Enzalutamide improves OS for metastatic …

www.healio.com
· Matthew Zibelman, MD. Data from this trial confirm that we have another potential option for men with metastatic hormone-sensitive prostate cancer. We knew that docetaxel and the …

Next-generation sequencing increases actionable mutation detection in...

www.healio.com
NEW YORK — The use of next-generation sequencing in multi-gene targeted panel testing identified a considerable number of actionable mutations among...
Save as document
+1